SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (17790)3/23/1998 12:18:00 PM
From: John O'Neill  Read Replies (1) | Respond to of 32384
 
Henry..you mentioned once that approval of Evista could be to LGND's advantage (I think you said that). Could this prob with Evista make a problem for LGND? . Also, I heard something on CNBC about diabetic drug (not LGND) beings developed with Pfizer. How do you think LGND's potential drugs in this area compare with competition?

JO